Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The aims of this collaborative, interdisciplinary research project are to understand and describe the psychological impact of the announcement of a rare, serious disease present since birth and detected in the context of the systematic neonatal screening (DNS), in terms of the parents' experience, but also on the part of the medical team, in order to improve its process and the support it provides for the announcement of the diagnosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Parent or doctor of a child screened for PKU, born during the inclusion phase of the study

Family's first exposure to PKU: the PKU child must be either the eldest or the first sibling to be diagnosed with PKU following neonatal screening

Disqualifiers

Failure to master the French language.

Child screened is neither the eldest nor the first sibling to be screened.

Refusal by the parents.

Any other reason which, in the investigator's judgement, would impair the participants' ability to follow the study protocol, or the interpretation of interview data (e.g. the participating parent has a history of serious psychiatric pathology, one of the parents died at the child's birth, Couples in which one of the members suffers from a known decompensated psychiatric pathology at the time of recruitment. Couples where one of the members is under legal protection or a security measure, etc …).

Trial population

Parent(s) of children screened for PKU, doctors in charge of the announcement and midwives in charge of the NBS.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • socio-psychological questionnaire

    Behavioral

    ton collecte socio-demographic variable

  • revised event impact scale (IER-S)

    Behavioral

    22 items assessed on a scale of frequency from 0 (not at all) to 4 (extremely)

  • Non directive interview

    Other intervention

    composed of a very broad opening sentence to encourage the parents' discourse

  • Stern interview

    Other intervention

    54 questions to investigate the impact of the announcement and the parenthood construction

  • semi-directive interview

    Other intervention

    to propose ideas for improving and harmonizing practices

Treatment groups

80 Participants
are divided into 4 treatment groups
Group A: groupe 12 interventions
Group B: groupe 24 interventions
Group C: groupe 31 intervention
Group D: groupe 41 intervention

Trial outcomes

Primary outcomes

1

Psychological process linked to the announcement of inherited metabolic disease for the parents

Identifying the psychological processes at work during and following the announcement of a child's illness (interview).

Time frame
4 and a half months
2

Psychological impact of the announcement of an inherited metabolic disease on the doctors' experience

interview.

Time frame
2 hours
3

Measuring awareness of inherited metabolic diseases detected by midwives

interview.

Time frame
1 hour

Secondary outcomes

1

Measure of the impact of the announcement on parents

Psychometric scale (IER-S )

Time frame
4 and a half months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assistance Publique - Hôpitaux de Paris

Lead sponsor

URC-CIC Paris Descartes Necker Cochin

Collaborator